IP Verse

A Rapamycin Derivative For Treating Lung Cancer - EP3143995

PATENT ANALYSIS

Patent Details

Grant Date
Dec 5, 2018
Company
NOVARTIS AG
Oppositions

ACCORD HEALTHCARE LTD

ETHYPHARM

GENERICS [UK] LTD

STADA ARZNEIMITTEL AG

SYNTHON B.V.

TEVA PHARMACEUTICAL INDUSTRIES LTD

ZENTIVA K.S.

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you